NEW YORK, Jan. 16 (GenomeWeb News) - AstraZeneca will extend its use of InforSense's informatics platform, InforSense said today.

 

InforSense, based in London, will build a new Open Discovery Workflow platform at AstraZeneca's research site in Molndal, Sweden, which will be accessed by researchers at several AstraZeneca sites.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.